| Authors: |
Göllner S; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany. stefanie.goellner@med.uni-heidelberg.de.; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. stefanie.goellner@med.uni-heidelberg.de., Oellerich T; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Agrawal-Singh S; Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Copenhagen, Denmark.; Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK., Schenk T; Institute of Cancer Research (ICR), Molecular Pathology, London, UK.; Department of Medicine II, Hematology and Oncology, University Hospital of Jena, Jena, Germany., Klein HU; Institute of Medical Informatics, University Hospital of Münster, Münster, Germany.; Department of Neurology, Columbia University, New York, New York, USA., Rohde C; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Pabst C; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Sauer T; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Lerdrup M; Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Copenhagen, Denmark.; Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Tavor S; Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel.; Department of Hematology, Assuta Medical Center, Tel Aviv, Israel., Stölzel F; Department of Medicine, Molecular Hematology, University Hospital Carl Gustav Carus, Dresden, Germany.; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Hematology and Oncology, University HospitalSchleswig-Holstein Kiel, Kiel, Germany., Herold S; Department of Medicine, Molecular Hematology, University Hospital Carl Gustav Carus, Dresden, Germany.; Institute of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany., Ehninger G; Department of Medicine, Molecular Hematology, University Hospital Carl Gustav Carus, Dresden, Germany., Köhler G; Gerhard Domagk Institute of Pathology, University of Münster, Münster, Germany.; Institute of Pathology, Klinikum Fulda gAG, Fulda, Germany., Pan KT; Bioanalytical Mass Spectrometry Group, Max Plank Institute for Biophysical Chemistry, Goettingen, Germany.; PreOmics GmbH, Planegg/Martinsried, Germany., Urlaub H; Bioanalytical Mass Spectrometry Group, Max Plank Institute for Biophysical Chemistry, Goettingen, Germany.; Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany., Serve H; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Dugas M; Institute of Medical Informatics, University Hospital of Münster, Münster, Germany.; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany., Spiekermann K; German Cancer Consortium (DKTK), Heidelberg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, University Hospital of Munich, Munich, Germany., Vick B; German Cancer Consortium (DKTK), Heidelberg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Research Unit Gene Vectors, Helmholtz Center Munich, Munich, Germany., Jeremias I; German Cancer Consortium (DKTK), Heidelberg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Research Unit Gene Vectors, Helmholtz Center Munich, Munich, Germany., Berdel WE; Department of Medicine A, Hematology and Oncology, University Hospital of Münster, Münster, Germany., Hansen K; Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Copenhagen, Denmark., Zelent A; Sylvester Comprehensive Cancer Center (UMHC), University of Miami Hospital and Clinics, Miami, Florida, USA.; Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzębiec, Poland., Wickenhauser C; Department of Pathology, University Hospital of Halle (Saale), Halle (Saale), Germany., Müller LP; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany., Thiede C; Department of Medicine, Molecular Hematology, University Hospital Carl Gustav Carus, Dresden, Germany., Müller-Tidow C; Department of Medicine IV, Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany. carsten.mueller-tidow@med.uni-heidelberg.de.; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. carsten.mueller-tidow@med.uni-heidelberg.de. |
